Response

We thank Belkacemi and colleagues for their interest in our recent work that evaluated the impact of regional nodal irradiation (RNI) in node-positive human epidermal growth factor receptor 2 (HER2)–positive breast cancer (BC). They made several arguments questioning the validity of our findings, and below we provide our response to their comments.

http://ift.tt/2zaaDXt